News

TSO3 RECEIVES US REGULATORY CLEARANCE FOR THE STERIZONE® VP4 STERILIZER

Wednesday, December 17, 2014

Québec City, December 17, 2014 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Corporation”) an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company has received US regulatory clearance, 510(k), for its STERIZONE® VP4 low temperature Sterilizer and its accessories. The clearance allows the Company to sell the product in the world’s largest sterilization market.

Read more

News

TSO3 ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER 2014

Wednesday, November 5, 2014

Quebec City, November 5, 2014 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in low temperature sterilization technology for medical devices in healthcare settings, today reported its financial results for the third quarter (Q3) ended September 30, 2014.

Read more

News

TSO3: Q3 2014 FINANCIAL RESULTS CONFERENCE CALL

Tuesday, October 28, 2014

Québec City, October 28, 2014 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Corporation”) an innovator in low temperature sterilization technology for medical devices in healthcare settings, will report Financial Results for the Third Quarter 2014 ended September 30, 2014 on Wednesday, November 5, 2014. TSO3 will host a Conference Call and a Webcast at 10:30 A.M. (EDT) the same day.

Read more

News

TSO3 IN LABEL REVIEW FOR ITS STERIZONE® STERILIZATION SYSTEM – Company to submit Final Labeling to US Regulatory Authorities for Sterilizer accessories

Wednesday, October 22, 2014

Québec City, October 22, 2014 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Corporation”) an innovator in sterilization technology for medical devices in healthcare settings, today announced that after a series of communications with US Regulatory Authorities, the Company has submitted revised labeling for the sterilizer, and is now finalizing labeling for accessory devices such as the Biological and Chemical Indicators used as part of the sterilization system. Such revisions are required so that all components of the entire system (sterilizer and accessories) can be in final review simultaneously.

Read more

News

TSO3 RESPONDS EARLY TO US REGULATORY AUTHORITIES ADDITIONAL INFORMATION REQUEST

Friday, September 19, 2014

Québec City, September 19, 2014 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Corporation”) an innovator in sterilization technology for medical devices in healthcare settings, today announced that the Company has officially submitted its response to the US Regulatory Authorities request for Additional Information. The response allows the Regulatory Authorities to continue their review for market clearance of the TSO3 STERIZONE® VP4 Sterilizer in the United States.

Read more